Study on the correlation between caspofungin blood concentration and therapeutic effect in invasive Candida infection

Status

Recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000033905

Enrollment

Unknown

Registered

2020-06-16

Start date

2020-06-01

Completion date

Unknown

Last updated

2020-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Invasive Candida

Interventions

experimental group:caspofungin

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients with invasive candidiasis (confirmed by pathogenic Culture); 2. Patients aged 18-75 years, both male and female; 3. Patients whose weight is in the range of 40kg-80kg; 4. Patients willing to participate in the study and sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients taking cyclosporine tacrolimus; 2. Patients combined with other antifungal drugs; 3. Pregnant or lactating women.

Design outcomes

Primary

Measure	Time frame
G test;	—

Secondary

Measure	Time frame
body temperature;Blood routine;Liver and kidney function;Fungal culture;	—

Countries

China

Contacts

Public ContactLiqing Wang

The Seventh Affiliated HospitaL

wliqing2014@163.com+86 1591842185, +86 755-81206188

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026